Trials by Condition
Showing 1 - 1 of 1 trials – Showing only trials currently accepting patients
-
Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
Stanford is currently accepting patients for this trial.